Targeting XBP-1 as a novel anti-cancer strategy

Cancer Biol Ther. 2006 Jul;5(7):756-9. doi: 10.4161/cbt.5.7.2973. Epub 2006 Jul 1.

Abstract

The survival and growth of tumor cells within the microenvironment of a solid tumor necessitates the adaptation of these cells to ER stress. Hypoxia, in the context of the tumor microenvironment, is a critical ER stress that activates the unfolded protein response (UPR). This review focuses on the role of the IRE1-XBP1 branch of the UPR and its role in mediating cell survival and tumor growth. Inhibition of this pathway will be discussed as a therapeutic strategy.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • DNA-Binding Proteins / antagonists & inhibitors*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Endoplasmic Reticulum / metabolism
  • Humans
  • Hypoxia / genetics
  • Hypoxia / metabolism*
  • Iron Regulatory Protein 1 / metabolism
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Protein Folding
  • Regulatory Factor X Transcription Factors
  • Transcription Factors / antagonists & inhibitors*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Up-Regulation
  • X-Box Binding Protein 1

Substances

  • DNA-Binding Proteins
  • Regulatory Factor X Transcription Factors
  • Transcription Factors
  • X-Box Binding Protein 1
  • XBP1 protein, human
  • Iron Regulatory Protein 1